According to the settlement website, anyone who purchased generic prescription drugs manufactured by any of the companies ...
A generic drug company has agreed to pay millions to settle claims of illegally inflating medication prices. The multistate ...
Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens ...
EyePoint Pharmaceuticals has agreed to pay the U.S. government $4,657,463.18 to resolve False Claims Act allegations tied to its ophthalmic drug DEXYCU. According to a July 17 news release by the ...
A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...
This figure reflects only the State's allocation and does not include separate settlement funds available to eligible ...